Tonabersat suppresses priming/activation of the NOD-like receptor protein-3 (NLRP3) inflammasome and decreases renal tubular epithelial-to-macrophage crosstalk in a model of diabetic kidney disease.

Autor: Cliff, C. L.1 (AUTHOR), Squires, P. E.1 (AUTHOR), Hills, C. E.1 (AUTHOR) chills@lincoln.ac.uk
Zdroj: Cell Communication & Signaling. 7/5/2024, Vol. 22 Issue 1, p1-23. 23p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje